APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Therapy (IV) Bottles

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Intravenous Therapy (IV) Bottles Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 July 2026194 pages

Choose your research edition.

Industry ResearchIntravenous Therapy (IV) Bottles Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Therapy (IV) Bottles Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Intravenous Therapy (IV) Bottles Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Therapy (IV) Bottles Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Therapy (IV) Bottles Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Intravenous Therapy (IV) Bottles market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Intravenous Therapy (IV) Bottles is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Intravenous Therapy (IV) Bottles is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intravenous Therapy (IV) Bottles is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Intravenous Therapy (IV) Bottles is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Intravenous Therapy (IV) Bottles include Vioser SA, Technoflex S.A, Sippex, Polycine GmbH, Metrix Company, Medicopack A/S, Kraton Corporation, JW Life Science and JOTOP Glass, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Intravenous Therapy (IV) Bottles market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Intravenous Therapy (IV) Bottles and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Intravenous Therapy (IV) Bottles sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Intravenous Therapy (IV) Bottles market size, projected growth trends, production technologies, key applications, and end-use industries.

Intravenous Therapy (IV) Bottles Segment by Company

Vioser SA

Technoflex S.A

Sippex

Polycine GmbH

Metrix Company

Medicopack A/S

Kraton Corporation

JW Life Science

JOTOP Glass

ICU Medical

Fresenius AG

Euro Healthcare Pvt. Ltd.

Baxter Healthcare Limited

Bausch Group

B. Braun

Intravenous Therapy (IV) Bottles Segment by Type

Plastic IV Bottles

Glass IV Bottle

Intravenous Therapy (IV) Bottles Segment by Application

Hospital

Clinic

Others

Intravenous Therapy (IV) Bottles Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Therapy (IV) Bottles market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Therapy (IV) Bottles and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Therapy (IV) Bottles.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Intravenous Therapy (IV) Bottles market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intravenous Therapy (IV) Bottles manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Intravenous Therapy (IV) Bottles in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Intravenous Therapy (IV) Bottles in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Intravenous Therapy (IV) Bottles Industry Trends Table 2. Intravenous Therapy (IV) Bottles Industry Drivers Table 3. Intravenous Therapy (IV) Bottles Industry Opportunities and Challenges Table 4. Intravenous Therapy (IV) Bottles Industry Restraints Table 5. Global Intravenous Therapy (IV) Bottles Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Intravenous Therapy (IV) Bottles Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Intravenous Therapy (IV) Bottles Sales Market Share by Manufacturers Table 9. Global Intravenous Therapy (IV) Bottles Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Intravenous Therapy (IV) Bottles Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Intravenous Therapy (IV) Bottles Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Intravenous Therapy (IV) Bottles Manufacturers, Product Type & Application Table 13. Global Intravenous Therapy (IV) Bottles Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Intravenous Therapy (IV) Bottles by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Plastic IV Bottles Table 17. Major Manufacturers of Glass IV Bottle Table 18. Global Intravenous Therapy (IV) Bottles Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Intravenous Therapy (IV) Bottles Sales by Type (2021-2026) & (k units) Table 20. Global Intravenous Therapy (IV) Bottles Sales by Type (2027-2032) & (k units) Table 21. Global Intravenous Therapy (IV) Bottles Sales Market Share by Type (2021-2026) Table 22. Global Intravenous Therapy (IV) Bottles Sales Market Share by Type (2027-2032) Table 23. Global Intravenous Therapy (IV) Bottles Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Intravenous Therapy (IV) Bottles Revenue by Type (2021-2026) & (k units) Table 25. Global Intravenous Therapy (IV) Bottles Revenue by Type (2027-2032) & (k units) Table 26. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Type (2021-2026) Table 27. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Others Table 31. Global Intravenous Therapy (IV) Bottles Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Intravenous Therapy (IV) Bottles Sales by Application (2021-2026) & (k units) Table 33. Global Intravenous Therapy (IV) Bottles Sales by Application (2027-2032) & (k units) Table 34. Global Intravenous Therapy (IV) Bottles Sales Market Share by Application (2021-2026) Table 35. Global Intravenous Therapy (IV) Bottles Sales Market Share by Application (2027-2032) Table 36. Global Intravenous Therapy (IV) Bottles Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Intravenous Therapy (IV) Bottles Revenue by Application (2021-2026) & (k units) Table 38. Global Intravenous Therapy (IV) Bottles Revenue by Application (2027-2032) & (k units) Table 39. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Application (2021-2026) Table 40. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Application (2027-2032) Table 41. Global Intravenous Therapy (IV) Bottles Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Intravenous Therapy (IV) Bottles Sales by Region (2021-2026) & (k units) Table 43. Global Intravenous Therapy (IV) Bottles Sales Market Share by Region (2021-2026) Table 44. Global Intravenous Therapy (IV) Bottles Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Intravenous Therapy (IV) Bottles Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Intravenous Therapy (IV) Bottles Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Intravenous Therapy (IV) Bottles Sales by Country (2021-2026) & (k units) Table 48. North America Intravenous Therapy (IV) Bottles Sales by Country (2027-2032) & (k units) Table 49. Europe Intravenous Therapy (IV) Bottles Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Intravenous Therapy (IV) Bottles Sales by Country (2021-2026) & (k units) Table 51. Europe Intravenous Therapy (IV) Bottles Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Intravenous Therapy (IV) Bottles Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Intravenous Therapy (IV) Bottles Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Intravenous Therapy (IV) Bottles Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Intravenous Therapy (IV) Bottles Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Intravenous Therapy (IV) Bottles Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Intravenous Therapy (IV) Bottles Sales by Country (2027-2032) & (k units) Table 58. Global Intravenous Therapy (IV) Bottles Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Intravenous Therapy (IV) Bottles Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Intravenous Therapy (IV) Bottles Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Region (2021-2026) Table 62. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Region (2027-2032) Table 63. Vioser SA Company Information Table 64. Vioser SA Business Overview Table 65. Vioser SA Intravenous Therapy (IV) Bottles Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Vioser SA Intravenous Therapy (IV) Bottles Product Portfolio Table 67. Vioser SA Recent Development Table 68. Technoflex S.A Company Information Table 69. Technoflex S.A Business Overview Table 70. Technoflex S.A Intravenous Therapy (IV) Bottles Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Technoflex S.A Intravenous Therapy (IV) Bottles Product Portfolio Table 72. Technoflex S.A Recent Development Table 73. Sippex Company Information Table 74. Sippex Business Overview Table 75. Sippex Intravenous Therapy (IV) Bottles Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sippex Intravenous Therapy (IV) Bottles Product Portfolio Table 77. Sippex Recent Development Table 78. Polycine GmbH Company Information Table 79. Polycine GmbH Business Overview Table 80. Polycine GmbH Intravenous Therapy (IV) Bottles Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Polycine GmbH Intravenous Therapy (IV) Bottles Product Portfolio Table 82. Polycine GmbH Recent Development Table 83. Metrix Company Company Information Table 84. Metrix Company Business Overview Table 85. Metrix Company Intravenous Therapy (IV) Bottles Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Metrix Company Intravenous Therapy (IV) Bottles Product Portfolio Table 87. Metrix Company Recent Development Table 88. Medicopack A/S Company Information Table 89. Medicopack A/S Business Overview Table 90. Medicopack A/S Intravenous Therapy (IV) Bottles Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Medicopack A/S Intravenous Therapy (IV) Bottles Product Portfolio Table 92. Medicopack A/S Recent Development Table 93. Kraton Corporation Company Information Table 94. Kraton Corporation Business Overview Table 95. Kraton Corporation Intravenous Therapy (IV) Bottles Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Kraton Corporation Intravenous Therapy (IV) Bottles Product Portfolio Table 97. Kraton Corporation Recent Development Table 98. JW Life Science Company Information Table 99. JW Life Science Business Overview Table 100. JW Life Science Intravenous Therapy (IV) Bottles Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. JW Life Science Intravenous Therapy (IV) Bottles Product Portfolio Table 102. JW Life Science Recent Development Table 103. JOTOP Glass Company Information Table 104. JOTOP Glass Business Overview Table 105. JOTOP Glass Intravenous Therapy (IV) Bottles Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. JOTOP Glass Intravenous Therapy (IV) Bottles Product Portfolio Table 107. JOTOP Glass Recent Development Table 108. ICU Medical Company Information Table 109. ICU Medical Business Overview Table 110. ICU Medical Intravenous Therapy (IV) Bottles Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. ICU Medical Intravenous Therapy (IV) Bottles Product Portfolio Table 112. ICU Medical Recent Development Table 113. Fresenius AG Company Information Table 114. Fresenius AG Business Overview Table 115. Fresenius AG Intravenous Therapy (IV) Bottles Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Fresenius AG Intravenous Therapy (IV) Bottles Product Portfolio Table 117. Fresenius AG Recent Development Table 118. Euro Healthcare Pvt. Ltd. Company Information Table 119. Euro Healthcare Pvt. Ltd. Business Overview Table 120. Euro Healthcare Pvt. Ltd. Intravenous Therapy (IV) Bottles Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Euro Healthcare Pvt. Ltd. Intravenous Therapy (IV) Bottles Product Portfolio Table 122. Euro Healthcare Pvt. Ltd. Recent Development Table 123. Baxter Healthcare Limited Company Information Table 124. Baxter Healthcare Limited Business Overview Table 125. Baxter Healthcare Limited Intravenous Therapy (IV) Bottles Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Baxter Healthcare Limited Intravenous Therapy (IV) Bottles Product Portfolio Table 127. Baxter Healthcare Limited Recent Development Table 128. Bausch Group Company Information Table 129. Bausch Group Business Overview Table 130. Bausch Group Intravenous Therapy (IV) Bottles Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Bausch Group Intravenous Therapy (IV) Bottles Product Portfolio Table 132. Bausch Group Recent Development Table 133. B. Braun Company Information Table 134. B. Braun Business Overview Table 135. B. Braun Intravenous Therapy (IV) Bottles Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. B. Braun Intravenous Therapy (IV) Bottles Product Portfolio Table 137. B. Braun Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Intravenous Therapy (IV) Bottles Distributors List Table 141. Intravenous Therapy (IV) Bottles Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Intravenous Therapy (IV) Bottles Product Image Figure 2. Global Intravenous Therapy (IV) Bottles Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous Therapy (IV) Bottles Market Size (2021-2032) & (US$ Million) Figure 4. Global Intravenous Therapy (IV) Bottles Sales (2021-2032) & (k units) Figure 5. Global Intravenous Therapy (IV) Bottles Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Intravenous Therapy (IV) Bottles Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Plastic IV Bottles Image Figure 9. Glass IV Bottle Image Figure 10. Global Intravenous Therapy (IV) Bottles Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Intravenous Therapy (IV) Bottles Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Intravenous Therapy (IV) Bottles Sales Market Share by Type (2021-2032) Figure 13. Global Intravenous Therapy (IV) Bottles Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Intravenous Therapy (IV) Bottles Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Others Image Figure 19. Global Intravenous Therapy (IV) Bottles Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Intravenous Therapy (IV) Bottles Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Intravenous Therapy (IV) Bottles Sales Market Share by Application (2021-2032) Figure 22. Global Intravenous Therapy (IV) Bottles Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Intravenous Therapy (IV) Bottles Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Application (2021-2032) Figure 25. North America Intravenous Therapy (IV) Bottles Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Intravenous Therapy (IV) Bottles Sales Market Share by Country (2021-2032) Figure 27. U.S. Intravenous Therapy (IV) Bottles Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Intravenous Therapy (IV) Bottles Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Intravenous Therapy (IV) Bottles Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Intravenous Therapy (IV) Bottles Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Intravenous Therapy (IV) Bottles Sales Market Share by Country (2021-2032) Figure 32. Germany Intravenous Therapy (IV) Bottles Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Intravenous Therapy (IV) Bottles Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Intravenous Therapy (IV) Bottles Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Intravenous Therapy (IV) Bottles Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Intravenous Therapy (IV) Bottles Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Intravenous Therapy (IV) Bottles Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Intravenous Therapy (IV) Bottles Sales Market Share by Country (2021-2032) Figure 39. China Intravenous Therapy (IV) Bottles Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Intravenous Therapy (IV) Bottles Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Intravenous Therapy (IV) Bottles Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Intravenous Therapy (IV) Bottles Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Intravenous Therapy (IV) Bottles Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Intravenous Therapy (IV) Bottles Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Intravenous Therapy (IV) Bottles Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Intravenous Therapy (IV) Bottles Sales Market Share by Country (2021-2032) Figure 47. Brazil Intravenous Therapy (IV) Bottles Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Intravenous Therapy (IV) Bottles Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Intravenous Therapy (IV) Bottles Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Intravenous Therapy (IV) Bottles Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Intravenous Therapy (IV) Bottles Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Intravenous Therapy (IV) Bottles Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Intravenous Therapy (IV) Bottles Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Intravenous Therapy (IV) Bottles Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Intravenous Therapy (IV) Bottles Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Figure 58. North America Intravenous Therapy (IV) Bottles Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Figure 60. Europe Intravenous Therapy (IV) Bottles Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Intravenous Therapy (IV) Bottles Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Intravenous Therapy (IV) Bottles Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Intravenous Therapy (IV) Bottles Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Intravenous Therapy (IV) Bottles Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Intravenous Therapy (IV) Bottles Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Plastic IV Bottles
  • Glass IV Bottle
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Vioser SA
  • Technoflex S.A
  • Sippex
  • Polycine GmbH
  • Metrix Company
  • Medicopack A/S
  • Kraton Corporation
  • JW Life Science
  • JOTOP Glass
  • ICU Medical
  • Fresenius AG
  • Euro Healthcare Pvt. Ltd.
  • Baxter Healthcare Limited
  • Bausch Group
  • B. Braun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Intravenous Therapy (IV) Bottles Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Intravenous Therapy (IV) Bottles Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Intravenous Therapy (IV) Bottles Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Intravenous Therapy (IV) Bottles Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Intravenous Therapy (IV) Bottles Market Dynamics
  1. 2.1 Intravenous Therapy (IV) Bottles Industry Trends
  2. 2.2 Intravenous Therapy (IV) Bottles Industry Drivers
  3. 2.3 Intravenous Therapy (IV) Bottles Industry Opportunities and Challenges
  4. 2.4 Intravenous Therapy (IV) Bottles Industry Restraints
3 Intravenous Therapy (IV) Bottles Market by Manufacturers
  1. 3.1 Global Intravenous Therapy (IV) Bottles Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Intravenous Therapy (IV) Bottles Sales by Manufacturers (2021-2026)
  3. 3.3 Global Intravenous Therapy (IV) Bottles Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Intravenous Therapy (IV) Bottles Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Intravenous Therapy (IV) Bottles Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Intravenous Therapy (IV) Bottles Manufacturers, Product Type & Application
  7. 3.7 Global Intravenous Therapy (IV) Bottles Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Intravenous Therapy (IV) Bottles Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Intravenous Therapy (IV) Bottles Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Intravenous Therapy (IV) Bottles Tier 1, Tier 2, and Tier 3
4 Intravenous Therapy (IV) Bottles Market by Type
  1. 4.1 Intravenous Therapy (IV) Bottles Type Introduction
  2. 4.1.1 Plastic IV Bottles
  3. 4.1.2 Glass IV Bottle
  4. 4.2 Global Intravenous Therapy (IV) Bottles Sales by Type
  5. 4.2.1 Global Intravenous Therapy (IV) Bottles Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Intravenous Therapy (IV) Bottles Sales by Type (2021-2032)
  7. 4.2.3 Global Intravenous Therapy (IV) Bottles Sales Market Share by Type (2021-2032)
  8. 4.3 Global Intravenous Therapy (IV) Bottles Revenue by Type
  9. 4.3.1 Global Intravenous Therapy (IV) Bottles Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Intravenous Therapy (IV) Bottles Revenue by Type (2021-2032)
  11. 4.3.3 Global Intravenous Therapy (IV) Bottles Revenue Market Share by Type (2021-2032)
5 Intravenous Therapy (IV) Bottles Market by Application
  1. 5.1 Intravenous Therapy (IV) Bottles Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Intravenous Therapy (IV) Bottles Sales by Application
  6. 5.2.1 Global Intravenous Therapy (IV) Bottles Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Intravenous Therapy (IV) Bottles Sales by Application (2021-2032)
  8. 5.2.3 Global Intravenous Therapy (IV) Bottles Sales Market Share by Application (2021-2032)
  9. 5.3 Global Intravenous Therapy (IV) Bottles Revenue by Application
  10. 5.3.1 Global Intravenous Therapy (IV) Bottles Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Intravenous Therapy (IV) Bottles Revenue by Application (2021-2032)
  12. 5.3.3 Global Intravenous Therapy (IV) Bottles Revenue Market Share by Application (2021-2032)
6 Global Intravenous Therapy (IV) Bottles Sales by Region
  1. 6.1 Global Intravenous Therapy (IV) Bottles Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Intravenous Therapy (IV) Bottles Sales by Region (2021-2032)
  3. 6.2.1 Global Intravenous Therapy (IV) Bottles Sales by Region (2021-2026)
  4. 6.2.2 Global Intravenous Therapy (IV) Bottles Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Intravenous Therapy (IV) Bottles Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Intravenous Therapy (IV) Bottles Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Intravenous Therapy (IV) Bottles Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Intravenous Therapy (IV) Bottles Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Intravenous Therapy (IV) Bottles Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Intravenous Therapy (IV) Bottles Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Intravenous Therapy (IV) Bottles Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Intravenous Therapy (IV) Bottles Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Intravenous Therapy (IV) Bottles Revenue by Region
  1. 7.1 Global Intravenous Therapy (IV) Bottles Revenue by Region
  2. 7.1.1 Global Intravenous Therapy (IV) Bottles Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Intravenous Therapy (IV) Bottles Revenue by Region (2021-2026)
  4. 7.1.3 Global Intravenous Therapy (IV) Bottles Revenue by Region (2027-2032)
  5. 7.1.4 Global Intravenous Therapy (IV) Bottles Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Intravenous Therapy (IV) Bottles Revenue (2021-2032)
  8. 7.2.2 North America Intravenous Therapy (IV) Bottles Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Intravenous Therapy (IV) Bottles Revenue (2021-2032)
  11. 7.3.2 Europe Intravenous Therapy (IV) Bottles Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Intravenous Therapy (IV) Bottles Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Intravenous Therapy (IV) Bottles Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Intravenous Therapy (IV) Bottles Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Intravenous Therapy (IV) Bottles Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Vioser SA
  2. 8.1.1 Vioser SA Company Information
  3. 8.1.2 Vioser SA Business Overview
  4. 8.1.3 Vioser SA Intravenous Therapy (IV) Bottles Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Vioser SA Intravenous Therapy (IV) Bottles Product Portfolio
  6. 8.1.5 Vioser SA Recent Developments
  7. 8.2 Technoflex S.A
  8. 8.2.1 Technoflex S.A Company Information
  9. 8.2.2 Technoflex S.A Business Overview
  10. 8.2.3 Technoflex S.A Intravenous Therapy (IV) Bottles Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Technoflex S.A Intravenous Therapy (IV) Bottles Product Portfolio
  12. 8.2.5 Technoflex S.A Recent Developments
  13. 8.3 Sippex
  14. 8.3.1 Sippex Company Information
  15. 8.3.2 Sippex Business Overview
  16. 8.3.3 Sippex Intravenous Therapy (IV) Bottles Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sippex Intravenous Therapy (IV) Bottles Product Portfolio
  18. 8.3.5 Sippex Recent Developments
  19. 8.4 Polycine GmbH
  20. 8.4.1 Polycine GmbH Company Information
  21. 8.4.2 Polycine GmbH Business Overview
  22. 8.4.3 Polycine GmbH Intravenous Therapy (IV) Bottles Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Polycine GmbH Intravenous Therapy (IV) Bottles Product Portfolio
  24. 8.4.5 Polycine GmbH Recent Developments
  25. 8.5 Metrix Company
  26. 8.5.1 Metrix Company Company Information
  27. 8.5.2 Metrix Company Business Overview
  28. 8.5.3 Metrix Company Intravenous Therapy (IV) Bottles Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Metrix Company Intravenous Therapy (IV) Bottles Product Portfolio
  30. 8.5.5 Metrix Company Recent Developments
  31. 8.6 Medicopack A/S
  32. 8.6.1 Medicopack A/S Company Information
  33. 8.6.2 Medicopack A/S Business Overview
  34. 8.6.3 Medicopack A/S Intravenous Therapy (IV) Bottles Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Medicopack A/S Intravenous Therapy (IV) Bottles Product Portfolio
  36. 8.6.5 Medicopack A/S Recent Developments
  37. 8.7 Kraton Corporation
  38. 8.7.1 Kraton Corporation Company Information
  39. 8.7.2 Kraton Corporation Business Overview
  40. 8.7.3 Kraton Corporation Intravenous Therapy (IV) Bottles Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Kraton Corporation Intravenous Therapy (IV) Bottles Product Portfolio
  42. 8.7.5 Kraton Corporation Recent Developments
  43. 8.8 JW Life Science
  44. 8.8.1 JW Life Science Company Information
  45. 8.8.2 JW Life Science Business Overview
  46. 8.8.3 JW Life Science Intravenous Therapy (IV) Bottles Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 JW Life Science Intravenous Therapy (IV) Bottles Product Portfolio
  48. 8.8.5 JW Life Science Recent Developments
  49. 8.9 JOTOP Glass
  50. 8.9.1 JOTOP Glass Company Information
  51. 8.9.2 JOTOP Glass Business Overview
  52. 8.9.3 JOTOP Glass Intravenous Therapy (IV) Bottles Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 JOTOP Glass Intravenous Therapy (IV) Bottles Product Portfolio
  54. 8.9.5 JOTOP Glass Recent Developments
  55. 8.10 ICU Medical
  56. 8.10.1 ICU Medical Company Information
  57. 8.10.2 ICU Medical Business Overview
  58. 8.10.3 ICU Medical Intravenous Therapy (IV) Bottles Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 ICU Medical Intravenous Therapy (IV) Bottles Product Portfolio
  60. 8.10.5 ICU Medical Recent Developments
  61. 8.11 Fresenius AG
  62. 8.11.1 Fresenius AG Company Information
  63. 8.11.2 Fresenius AG Business Overview
  64. 8.11.3 Fresenius AG Intravenous Therapy (IV) Bottles Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Fresenius AG Intravenous Therapy (IV) Bottles Product Portfolio
  66. 8.11.5 Fresenius AG Recent Developments
  67. 8.12 Euro Healthcare Pvt. Ltd.
  68. 8.12.1 Euro Healthcare Pvt. Ltd. Company Information
  69. 8.12.2 Euro Healthcare Pvt. Ltd. Business Overview
  70. 8.12.3 Euro Healthcare Pvt. Ltd. Intravenous Therapy (IV) Bottles Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Euro Healthcare Pvt. Ltd. Intravenous Therapy (IV) Bottles Product Portfolio
  72. 8.12.5 Euro Healthcare Pvt. Ltd. Recent Developments
  73. 8.13 Baxter Healthcare Limited
  74. 8.13.1 Baxter Healthcare Limited Company Information
  75. 8.13.2 Baxter Healthcare Limited Business Overview
  76. 8.13.3 Baxter Healthcare Limited Intravenous Therapy (IV) Bottles Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Baxter Healthcare Limited Intravenous Therapy (IV) Bottles Product Portfolio
  78. 8.13.5 Baxter Healthcare Limited Recent Developments
  79. 8.14 Bausch Group
  80. 8.14.1 Bausch Group Company Information
  81. 8.14.2 Bausch Group Business Overview
  82. 8.14.3 Bausch Group Intravenous Therapy (IV) Bottles Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bausch Group Intravenous Therapy (IV) Bottles Product Portfolio
  84. 8.14.5 Bausch Group Recent Developments
  85. 8.15 B. Braun
  86. 8.15.1 B. Braun Company Information
  87. 8.15.2 B. Braun Business Overview
  88. 8.15.3 B. Braun Intravenous Therapy (IV) Bottles Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 B. Braun Intravenous Therapy (IV) Bottles Product Portfolio
  90. 8.15.5 B. Braun Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Intravenous Therapy (IV) Bottles Value Chain Analysis
  2. 9.1.1 Intravenous Therapy (IV) Bottles Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Intravenous Therapy (IV) Bottles Production Mode & Process
  6. 9.2 Intravenous Therapy (IV) Bottles Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Intravenous Therapy (IV) Bottles Distributors
  9. 9.2.3 Intravenous Therapy (IV) Bottles Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst